Development of GABA<sub>A</sub> receptor positive allosteric modulator S-812217 (zuranolone) and research of antidepressant action mechanism related with amygdala.

Keiko Takasu

Presentation information

[JSNP/JSCNP joint meeting] Symposia

JSNP/JSCNP joint meeting » Symposia

Symposium 14
Recent Advance in Research and Development of Novel Antidepressants

Sat. May 25, 2024 2:25 PM - 3:40 PM Room 12 (Hall D5)

Chair: Shigeyuki Chaki (Research Headquarters, Taisho Pharmaceutical Co., Ltd.), Haruhide Kimura (Neuroscience Drug Discovery Unit, Research,Takeda Pharmaceutical Co. Ltd.)

[JSY14-2] Development of GABA_A receptor positive allosteric modulator S-812217 (zuranolone) and research of antidepressant action mechanism related with amygdala.

*Keiko Takasu¹, Yosuke Yawata¹, Ryoichi Tashima¹, Hiroyuki Aritomi², Shinji Shimada², Tomoko Motomiya¹, Koichi Ogawa¹ (1. Shionogi & Co., Ltd, 2. Shionogi TechnoAdvance Research)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

« Previous in this session
Next in this session »

▲

Presentation information

Symposium 14Recent Advance in Research and Development of Novel Antidepressants

[JSY14-2] Development of GABAA receptor positive allosteric modulator S-812217 (zuranolone) and research of antidepressant action mechanism related with amygdala.

Password

Symposium 14
Recent Advance in Research and Development of Novel Antidepressants

[JSY14-2] Development of GABA_A receptor positive allosteric modulator S-812217 (zuranolone) and research of antidepressant action mechanism related with amygdala.